Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Duos Technologies Reports Record 2025 Results, Driving Momentum in AI and Edge Infrastructure
-
LanzaTech Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
LanzaTech Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
-
GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results
-
KULR Reports Fourth Quarter Revenue and Full-Year 2025 Financial Results
-
Edible Garden Reports 2025 Results — Accelerates Planned Expansion into Higher-Margin Ready-to-Drink (RTD) and Shelf-Stable CPG Platform
-
SalesCloser Technologies Announces Engagement of Market Maker & Strategic and Advisory Consulting Agreement
-
Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025
-
Scripps completes sale of WRTV in Indianapolis to Circle City Broadcasting
-
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
-
EagleNXT Provides Corporate Update and Reports Fiscal 2025 Financial Results
-
AXIS Capital to Release First Quarter Financial Results on April 29, 2026
-
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
-
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
-
dLocal to Report First Quarter 2026 Financial Results
-
Banzai Reports Fourth Quarter and Full Year 2025 Financial Results
-
Trust Stamp provides a comprehensive business briefing for Q1 of 2026 reporting strong progress across multiple business geographies and verticals
-
Trust Stamp filed its 10-K for the year ending December 31, 2025 reflecting strong growth in customer enrollments and user completions with a 33.6% year-on-year decrease in Comprehensive Operating Los
-
CMB.TECH announces final year results
-
BioAtla Announces Share Consolidation
-
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
-
Nano Dimension Announces Financial Results for the Fourth Quarter and Full Year 2025
-
Workhorse Group Reports Fourth Quarter and Full Year 2025 Results
-
Dave & Buster’s Reports Fourth Quarter and Fiscal Year End 2025 Financial Results
-
Global Crossing Airlines Reports Fleet Expansion Milestones and Participation in Upcoming Investor Conferences
-
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
-
Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
Barfresh Announces Fourth Quarter and Full Year 2025 Results
-
Birchtech Reports Fourth Quarter 2025 Financial Results
-
Rigetti Announces Novera QPU Sale to the University of Saskatchewan
-
SEALSQ Announces FY 2025 Audited Financial Results, Reaffirms Q1 2026 Expectations & FY 2026 Guidance, Updates on Partnerships and QS7001 Certification & Go-to-Market Execution
-
TOMI Environmental Solutions, Inc. Reports Full Year 2025 Financial Results and Outlines Growth Initiatives
-
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
-
Rekor Systems Reports Full Year 2025 Results
-
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
-
AVAX One Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
-
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
-
ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Diseas
-
authID Reports Financial and Operating Results for the Fourth Quarter 2025
-
SEALSQ Announces FY 2025 Audited Financial Results, Reaffirms Q1 2026 Expectations & FY 2026 Guidance, Updates on Partnerships and QS7001 Certification & Go-to-Market Execution
-
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
-
Datacentrex Announces Closing of $20.17 Million Public Offering
-
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
nCino Appoints Keith Kettell as Chief Revenue Officer to Lead Next Phase of Growth
-
Aqua Metals Reports 2025 Milestone Advancements, Strategic Progress, and Continued Commercialization Momentum
-
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
-
Spartacus Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 2, 2026
-
Digital Realty Schedules First Quarter 2026 Earnings Release and Conference Call

